Oppenheimer Initiates Coverage On iBio with Outperform Rating, Announces Price Target of $5
Benzinga Newsdesk 1 year ago
NewsPrice TargetInitiationAnalyst Ratings
Oppenheimer analyst Jay Olson initiates coverage on iBio (NASDAQ:IBIO) with a Outperform rating and announces Price Target of $5.
Oppenheimer analyst Jay Olson initiates coverage on iBio (NASDAQ:IBIO) with a Outperform rating and announces Price Target of $5.